["{\n\"step_by_step_thinking\": \"The question asks about deucravacitinib's effectiveness for psoriasis. However, none of the provided documents mention deucravacitinib. Deucravacitinib is a relatively new medication that was approved in 2021 for the treatment of adults with moderate-to-severe plaque psoriasis. Since this information is not available in the given documents, we need to rely on other sources or external knowledge. Therefore, it's necessary to conclude that the answer cannot be determined based solely on the provided documents.\",\n\"answer_choice\": B"]